Vext Science Crescita futura
Future criteri di controllo 5/6
Vext Science is forecast to grow earnings and revenue by 111.1% and 34.6% per annum respectively while EPS is expected to grow by 103.3% per annum.
Informazioni chiave
111.1%
Tasso di crescita degli utili
103.3%
Tasso di crescita dell'EPS
| Pharmaceuticals crescita degli utili | 18.0% |
| Tasso di crescita dei ricavi | 34.6% |
| Rendimento futuro del capitale proprio | n/a |
| Copertura analitica | Low |
| Ultimo aggiornamento | 29 Oct 2024 |
Aggiornamenti recenti sulla crescita futura
Nessun aggiornamento
Recent updates
Previsioni di crescita degli utili e dei ricavi
| Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
|---|---|---|---|---|---|
| 12/31/2026 | 103 | 17 | 11 | N/A | 1 |
| 12/31/2025 | 58 | 10 | 8 | 7 | 3 |
| 12/31/2024 | 37 | -1 | 6 | -1 | 4 |
| 6/30/2024 | 33 | -7 | -1 | 0 | N/A |
| 3/31/2024 | 34 | -2 | 2 | 4 | N/A |
| 12/31/2023 | 35 | 4 | 2 | 4 | N/A |
| 9/30/2023 | 35 | 5 | 4 | 6 | N/A |
| 6/30/2023 | 34 | 7 | 0 | 5 | N/A |
| 3/31/2023 | 34 | 9 | -2 | 3 | N/A |
| 12/31/2022 | 35 | 11 | -3 | 6 | N/A |
| 9/30/2022 | 37 | 6 | -3 | 8 | N/A |
| 6/30/2022 | 38 | 6 | 0 | 11 | N/A |
| 3/31/2022 | 39 | 6 | -10 | 12 | N/A |
| 12/31/2021 | 37 | 5 | -8 | 11 | N/A |
| 9/30/2021 | 34 | 5 | -9 | 8 | N/A |
| 6/30/2021 | 33 | 5 | -8 | 8 | N/A |
| 3/31/2021 | 30 | 4 | 2 | 6 | N/A |
| 12/31/2020 | 25 | 2 | -1 | 3 | N/A |
| 9/30/2020 | 22 | 0 | -2 | 2 | N/A |
| 6/30/2020 | 20 | 0 | -6 | 1 | N/A |
| 3/31/2020 | 20 | 0 | -6 | 0 | N/A |
| 12/31/2019 | 22 | 3 | -6 | 0 | N/A |
| 9/30/2019 | 23 | 4 | -5 | -1 | N/A |
| 6/30/2019 | 23 | 5 | -3 | -1 | N/A |
| 3/31/2019 | 21 | 4 | -1 | 0 | N/A |
| 12/31/2018 | 18 | 4 | 1 | 2 | N/A |
| 12/31/2017 | 15 | 4 | N/A | 2 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: VV5 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.8%).
Guadagni vs Mercato: VV5 is forecast to become profitable over the next 3 years, which is considered above average market growth.
Guadagni ad alta crescita: VV5 is expected to become profitable in the next 3 years.
Ricavi vs Mercato: VV5's revenue (34.6% per year) is forecast to grow faster than the German market (5.5% per year).
Ricavi ad alta crescita: VV5's revenue (34.6% per year) is forecast to grow faster than 20% per year.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Insufficient data to determine if VV5's Return on Equity is forecast to be high in 3 years time